Skip to content
Screener

Constellium CSTM A&T — Depreciation, Amortization And Impairment Charge

Other segment segments

P&ARP
$48M+6.7%
AS&I
$15M-11.8%
H&C
$1M-50.0%

Similar metrics at other companies

Everus Construction Group logo
ECGT&D — Depreciation and amortization expense
$6.88M+18.7%
The J.M. Smucker Company logo
SJMDepreciation, amortization, and impairment charges
$134.4M-87.8%
The J.M. Smucker Company logo
SJMOther — Depreciation, amortization, and impairment charges
$10.1M+9.8%
Orthofix Medical Inc. logo
OFIXDepreciation Amortization And Impairment
$13.27M-21.3%
Orthofix Medical Inc. logo
OFIXDepreciation Amortization And Impairment
$13.27M-21.3%
PRA Group logo
PRAADepreciation, amortization and impairment
$2.61M-3.3%

Other financials

Income statement

See full
Revenue$2.7B+30.7%
Gross profit$480.0M+82.5%
Net income$146.0M+306%
EPS (diluted)$1.04+316%

Balance sheet

See full
Cash & equivalents$163.0M+22.6%
Total debt$2.0B-10.8%
Total equity$1.2B+59.7%
Total assets$6.1B+13.1%

Cash flow

See full
Operating cash flow$161.0M+41.2%
CapEx$77.0M0.0%
Free cash flow$84.0M+127%

Valuation

See full
Market cap$3.88B+107%
Enterprise value$5.71B+43.7%
P/E7.1×
P/S0.4×+0.2×

Profitability

See full
Gross margin16.3%+4.0pp
Net margin5.7%
FCF margin2.3%+1.7pp

Returns & leverage

See full
Return on equity53.8%
Debt / equity1.6×-1.3×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by Constellium in its filing.

Tagged under the XBRL concept cstm:DepreciationAmortizationAndImpairmentCharge.

The source filing: Constellium’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 12:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001563411-26-000192
(in millions of U.S. dollars)Three months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
A&T(19)(18)(37)(35)
P&ARP(48)(45)(95)(89)
AS&I(15)(17)(35)(33)
H&C (A)(1)(2)(3)(3)
Total depreciation, amortization and impairment expense(83)(82)(170)(160)

Item 1. Financial Statements

FAQ

What is Constellium's A&T — depreciation, amortization and impairment charge?
Constellium (CSTM) reported A&T — depreciation, amortization and impairment charge of $19M in Q2 2026.
How has Constellium's A&T — depreciation, amortization and impairment charge changed year-over-year?
Constellium's A&T — depreciation, amortization and impairment charge increased by 5.6% year-over-year, from $18M to $19M.
What is the long-term trend for Constellium's A&T — depreciation, amortization and impairment charge?
Over 3 years (2022 to 2025), Constellium's A&T — depreciation, amortization and impairment charge has grown at a 1.5% compound annual growth rate (CAGR), from $67M to $70M.
What does A&T — depreciation, amortization and impairment charge mean?
Reflects the systematic allocation of the cost of tangible and intangible assets over their useful lives, including any write-downs. It provides insight into the aging of the segment's asset base and the intensity of capital consumption.

Ask your AI about Constellium's a&t — depreciation, amortization and impairment charge.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude